Improving Utilization of Lung Cancer Screening in Underserved PA Populations

Study summary

This study is an interventional study intended to assess the impact of a centralized outreach intervention that includes shared decision-making about lung cancer screening (LCS) in LCS-eligible primary care patients. The study's goal is to increase LCS rates compared to usual care and thus reduce lung cancer deaths.

Ask AI to explain this study

Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedEducational Materials and Decision Counseling

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 15, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?American College of Radiology

Study sponsor

Study overview

What this study is about

Purpose: Screening
Study type: Interventional
Phase: Not applicable
Sponsor: American College of Radiology
Interventions being studied: Other: Educational Materials and Decision Counseling

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Have an upcoming office visit with a primary care physician in one of the study practices
Between the ages of 50 and 77 (inclusive)
History of smoking (current or former) in the electronic medical record (EMR)

Reasons someone may not be able to joinExclusion criteria

Chest CT performed in the last 10 months before study initiation according to EMR
Diagnosis of lung cancer indicated in the problem list in the EMR
Current cancer treatment or other qualifying diagnoses that would make outreach inappropriate (e.g., dementia, hearing disability)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Lehigh Valley Health NetworkAllentown, Pennsylvania
Jefferson Health SystemPhiladelphia, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 15, 2024. Always confirm current availability with the study team.

View original record ↗